_____________________

back  

The French Nanomedicine Society (SFNano) was launched on January 1, 2014 with the desire to continue to best represent the actors in the field of Nanomedicine in France.
Initially, Thematic Group for Research on Vectorization (GTRV), SFNano wishes to work in continuity while rising to the challenges of today.

The main objective of this non-profit association, under the French law of 1901, is to promote the progress and dissemination of knowledge in the field of nanomedicine, and to encourage exchanges between players in the field in the academic and industrial sectors, in France and beyond, with our European neighbors.

“The term nanomedicine, as defined by the ETPN, includes any nanotechnology whose purpose is diagnosis, therapy, imaging or theranostics. It also includes all aspects of vectorization and delivery, i.e., all approaches to transport biologically active molecules to their biological target (molecular vectors, nanoparticles, microparticles, “smart” systems, implants, tissue reconstruction…).”

_____________________

 Back 

Also to be read